Filed: 11/10/2022ACC: 0001012975-22-000487
📋 What this filing means
ARCH VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $771.4K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$771.4K
Total AUM (reported)
72.88M
Total Shares
Allocation by class
COM$771.4K100.0%
Portfolio Concentration
Top 3$587.8K76.2%
4–10$183.6K23.8%
Top 3 weight
76.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 72.88M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
72.88M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole10
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings10
Rows:
KARUNA THERAPEUTICS, INC.
SOLEShares1.31M
TypeSH
Market value$295.3K
38.28%
Sole
0.00
Shared
0.00
None
1.31M
EQRX, INC.
SOLEShares36.34M
TypeSH
Market value$179.9K
23.32%
Sole
0.00
Shared
0.00
None
36.34M
DENALI THERAPEUTICS, INC.
SOLEShares3.67M
TypeSH
Market value$112.6K
14.60%
Sole
0.00
Shared
0.00
None
3.67M
ERASCA, INC.
SOLEShares11.06M
TypeSH
Market value$86.2K
11.18%
Sole
0.00
Shared
0.00
None
11.06M
VERVE THERAPEUTICS, INC.
SOLEShares2.01M
TypeSH
Market value$69.0K
8.95%
Sole
0.00
Shared
0.00
None
2.01M
REVOLUTION HEALTHCARE ACQUISITION CORP.
SOLEShares1.36M
TypeSH
Market value$13.3K
1.73%
Sole
0.00
Shared
0.00
None
1.36M
SINGULAR GENOMICS SYSTEMS, INC.
SOLEShares3.80M
TypeSH
Market value$9.5K
1.23%
Sole
0.00
Shared
0.00
None
3.80M
UNITY BIOTECHNOLOGY, INC.
SOLEShares10.05M
TypeSH
Market value$4.0K
0.51%
Sole
0.00
Shared
0.00
None
10.05M
METACRINE, INC.
SOLEShares2.94M
TypeSH
Market value$1.4K
0.18%
Sole
0.00
Shared
0.00
None
2.94M
RUBIUS THERAPEUTICS, INC.
SOLEShares349.91K
TypeSH
Market value$152.00
0.02%
Sole
0.00
Shared
0.00
None
349.91K
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KARUNA THERAPEUTICS, INC.SOLE | COM | 1.31M | SH | $295.3K 38.28% | 0.00 | 0.00 | 1.31M |
EQRX, INC.SOLE | COM | 36.34M | SH | $179.9K 23.32% | 0.00 | 0.00 | 36.34M |
DENALI THERAPEUTICS, INC.SOLE | COM | 3.67M | SH | $112.6K 14.60% | 0.00 | 0.00 | 3.67M |
ERASCA, INC.SOLE | COM | 11.06M | SH | $86.2K 11.18% | 0.00 | 0.00 | 11.06M |
VERVE THERAPEUTICS, INC.SOLE | COM | 2.01M | SH | $69.0K 8.95% | 0.00 | 0.00 | 2.01M |
REVOLUTION HEALTHCARE ACQUISITION CORP.SOLE | COM | 1.36M | SH | $13.3K 1.73% | 0.00 | 0.00 | 1.36M |
SINGULAR GENOMICS SYSTEMS, INC.SOLE | COM | 3.80M | SH | $9.5K 1.23% | 0.00 | 0.00 | 3.80M |
UNITY BIOTECHNOLOGY, INC.SOLE | COM | 10.05M | SH | $4.0K 0.51% | 0.00 | 0.00 | 10.05M |
METACRINE, INC.SOLE | COM | 2.94M | SH | $1.4K 0.18% | 0.00 | 0.00 | 2.94M |
RUBIUS THERAPEUTICS, INC.SOLE | COM | 349.91K | SH | $152.00 0.02% | 0.00 | 0.00 | 349.91K |